| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
Icotinib Hydrochloride
|
1204313-51-8 |
凯美纳
|
Icotinib (Hydrochloride);N-(3-Ethynylphenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododecino[2,3-g]quinazolin-4-amine hydrochloride;Icotinib Hydrochloride (BPI-2009);N-(3-Ethynylphenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododecino[2,3-g]quinazolin-4-amine hydrochloride Icotinib (Hydrochloride);Icotinib HCl
|
|||
|
Tenovin 6-Tnv 6
|
1011557-82-6 |
TENOVIN-6
|
4-TERT-BUTYL-N-(4-(5-(DIMETHYLAMINO)PENTANAMIDO)PHENYLCARBAMOTHIOYL)BENZAMIDE HYDROCHLORIDE;TENOVIN-6,SIRT 抑制剂和 P53 激活剂;TENOVIN 6;TENOVIN6
|
C25H34N4O2S |
454.62806 | 200-256-5 |
|
PF-3758309
|
898044-15-0 |
PF-375839
|
PF 3758309;PF3758309;CS-1014
|
C25H30N8OS |
490.6237 | |
|
OTX015
|
202590-98-5 |
OTX-15
|
CS-1013;(S)-4-(4-氯苯基)-N-(4-羟基苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]三唑并[4,3-A][1,4]二氮杂卓-6-乙酰胺;OTX 015; OTX015;MK-8628; MK 8628; MK8628;OTX-015;OTX015;OTX 015;OTX-015;(4-氯苯基)-N-(4-羟基苯基)-2,4]二氮杂卓-6-乙酰胺;比拉瑞塞
|
C25H22ClN5O2S |
491.99248 | |
|
PNU 282987
|
123464-89-1 |
PNU-282987
|
N-(3R)-1-氮杂双环[2,2,2]辛-3-基-4-氯苯甲酰胺盐酸盐
|
C14H17ClN2O |
264.75058 | |
|
Skepinone-L
|
1221485-83-1 |
SKEPINONE-L
|
CS-1010;SKEPINONE
|
C24H21F2NO4 |
425.424646 | |
|
SALUBRINAL
|
405060-95-9 |
SALUBRINAL
|
SALUBRINAL抑制剂;CS-1008;EIF-2Α INHIBITOR
|
C21H17Cl3N4OS |
479.81 | |
|
HS-173
|
1276110-06-5 |
HS-173
|
CS-1007;HS 173;HS173;6-[5-[(苯磺酰基)氨基]-3-吡啶基]咪唑并[1,2-A]吡啶-3-羧酸乙酯;HS-173,一种新颖的 PI3K 抑制剂
|
C21H18N4O4S |
422.45702 | |
|
TTNPB
|
71441-28-6 |
TTNPB (Arotinoid Acid)
|
芳维甲酸;RO 13-7410;AROTINOID ACID;AGN191183;AGN-191183;4-[(E)-2-(5,6,7,8-四氢-5,5,8,8-四甲基-2-萘基)-1-丙烯基]苯甲酸;RO 13-7410;AROTINOID ACID;AGN191183;RO 13-7410;AGN-191183
|
C24H28O2 |
348.48 | |
|
ZLN005
|
49671-76-3 |
ZLN-5
|
ZLN 005; ZLN-005;2-(4-TERT-BUTYLPHENYL)-1H-BENZO[D]IMIDAZOLE;2-(4-叔丁基苯基)苯并咪唑
|
C17H18N2 |
250.33822 | |
|
TC-DAPK 6
|
315694-89-4 |
TC-DAPK 6
|
TC-DAPK 6;DAPK inhibitor;2-(2-Phenylethenyl)-4-(3-pyridinylmethylene)-5(4H)-oxazolone;2-(2-Phenylethenyl)-4-(3-pyridinylmethylene)-5(4H)-oxazolone TC-DAPK 6
|
|||
|
SKLB1002
|
1225451-84-2 |
SKLB12
|
CS-1002;6,7-二甲氧基-4-[(5-甲基-1,3,4-噻二唑-2-基)硫基]喹唑啉;4-噻二唑-2-基)硫基]喹唑啉;7-二甲氧基-4-[(5-甲基-1;SKLB 1002;SKLB-1002
|
C13H12N4O2S2 |
320.38998 | |
|
CNX-2006
|
1375465-09-0 |
CNX26
|
CNX2006;CNX 2006;CS-1000;N-[3-[[2-[[4-[[1-(2-氟乙基)-3-氮杂环丁基]氨基]-2-甲氧基苯基]氨基]-5-(三氟甲基)-4-嘧啶基]氨基]苯基]-2-丙烯酰胺;N-[3-[[2-[[4-[[1-(2-氟乙基)-3-氮杂啶]氨基]-2-甲氧基苯基]氨基]-5-(三氟甲基)-4-嘧啶]氨基]苯基]-2-丙酰胺
|
C26H27F4N7O2 |
545.531893 | |
|
UNC1999
|
1431612-23-5 |
UNC1999
|
CS-999;N-[(1,2-二氢-6-甲基-2-氧代-4-丙基-3-吡啶基)甲基]-1-(1-甲基乙基)-6-[6-[4-(1-甲基乙基)-1-哌嗪基]-3-吡啶基]-1H-吲唑-4-甲酰胺;UNC1999;UNC 1999;UNC1999;UNC-1999;UNC 1999;N-[(6-METHYL-2-OXO-4-PROPYL-1H-PYRIDIN-3-YL)METHYL]-1-PROPAN-2-YL-6-[6-(4-PROPAN-2-YLPIPERAZIN-1-YL)PYRIDIN-3-YL]INDAZOLE-4-CARBOXAMIDE
|
C33H43N7O2 |
569.74022 | |
|
WAY100635
|
1092679-51-0 |
WAY1635
|
WAY100635 100MG;通100635;CS-998;N-[2-[4-(2-甲氧基苯基)-1-哌嗪基]乙基]-N-2-吡啶基-环己烷甲酰胺马来酸盐
|
C29H38N4O6 |
538.63522 | |
|
GNF 5837
|
1033769-28-6 |
GNF 5837
|
GNF5837;GNF 5837;GNF-5837>97%;(Z)-1-(3-(3-((1H-PYRROL-2-YL)METHYLENE)-2-OXOINDOLIN-6-YLAMINO)-4-METHYLPHENYL)-3-(2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL)UREA;N-[3-[[2,3-二氢-2-氧代-3-(1H-吡咯-2-基亚甲基)-1H-吲哚-6-基]氨基]-4-甲基苯基]-N'-[2-氟-5-(三氟甲基)苯基]-脲;脲,N-[3-[[2,3-二氢-2-氧代-3-(1H-吡咯-2-基亚甲基)-1H-吲哚-6-基]氨基]-4-甲基苯基]-N'-[2-氟-5-(三氟甲基)苯基]-
|
C28H21F4N5O2 |
535.4922528 | |
|
PRT062607 Hydrochloride
|
1370261-97-4 |
PRT6267 (HYDROCHLORIDE)
|
CS-995;P505-15;PRT2607;PRT-2607;PRT 2607;PRT-062607;PRT 062607;P505-15;BIIB057;2-[[(1R,2S)-2-氨基环己基]氨基]-4-[[3-(2H-1,2,3-噻唑-2-基)苯基]氨基]-5-嘧啶羧酰胺盐酸盐;2-[[(1R,3-三唑-2-基)苯基]氨基]-5-嘧啶甲酰胺盐酸盐
|
C19H24ClN9O |
429.90656 | |
|
Ro5203280
|
1062243-51-9 |
RO328
|
|
C27H35F2N7O3 |
543.608706 | |
|
LDN-57444
|
668467-91-2 |
LDN-57444
|
UCH-L1 INHIBITOR;LDN57444;CS-988
|
C17H11Cl3N2O3 |
397.63984 | |
|
LCL-161
|
1005342-46-0 |
LCL161
|
凋亡蛋白抑制因子抑制剂
|
C26H33FN4O3S |
500.628623 |
药智官方微信
药智官方微博
